|
Real-time Estimate
Cboe BZX
20:52:12 23/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 74.40 USD | -3.47% |
|
-3.75% | -8.73% |
| Market Cap | 3.38B 2.97B 2.79B 2.55B 4.77B 324B 4.8B 33.52B 12.99B 165B 12.7B 12.42B 536B | P/E 2026 * |
-36.2x | P/E 2027 * | 33.2x |
|---|---|---|---|---|---|
| Enterprise Value | 3.38B 2.97B 2.79B 2.55B 4.77B 324B 4.8B 33.52B 12.99B 165B 12.7B 12.42B 536B | EV / Sales 2026 * |
4.73x | EV / Sales 2027 * | 3.72x |
| Free-Float |
97.31% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| TARS | Delayed | |
CBOE
| TARS | Real-time |
Last Transcript: Tarsus Pharmaceuticals, Inc.
| 1 day | -3.47% | ||
| 1 week | -3.75% | ||
| Current month | +0.66% | ||
| 1 month | +2.64% | ||
| 3 months | +12.94% | ||
| 6 months | +16.53% | ||
| Current year | -8.73% |
| 1 week | 74.44 |  | 79.78 |
| 1 month | 69.46 | | 91.53 |
| Current year | 53.89 | | 91.53 |
| 1 year | 53.89 | | 91.53 |
| 3 years | 12.57 | | 91.53 |
| 5 years | 10.8 | | 91.53 |
| 10 years | 10.8 | | 91.53 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bobak Azamian
CEO | Chief Executive Officer | 48 | 31/08/2018 |
Jeffrey Farrow
DFI | Director of Finance/CFO | 64 | 23/04/2023 |
| Chief Tech/Sci/R&D Officer | 47 | 03/11/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Bobak Azamian
CHM | Chairman | 48 | 01/12/2022 |
| Director/Board Member | 71 | 30/11/2019 | |
Bill Link
BRD | Director/Board Member | 80 | 31/12/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 15/09/26 | Exercice | Director | 604 | 0.0014% | ||
| 15/09/26 | Exercice | Director | 12,902 | 0.0294% | ||
| 15/09/26 | Exercice | Director | 402 | 0.0009% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.47% | -3.75% | +34.33% | +357.34% | 3.38B | |
| -0.19% | +3.60% | +41.31% | -3.85% | 80.27B | |
| -0.47% | +25.83% | +610.51% | +86.66% | 72.88B | |
| -0.82% | +2.86% | -10.04% | -28.92% | 61.51B | |
| -1.80% | -3.26% | -13.41% | +26.38% | 47.39B | |
| -0.89% | +0.81% | +2.47% | +157.67% | 46.58B | |
| +0.57% | +5.14% | +63.03% | -10.94% | 33.3B | |
| -1.87% | +0.13% | +47.75% | +112.61% | 25.73B | |
| +0.29% | +8.84% | +9.19% | +176.10% | 22.88B | |
| -1.92% | +0.05% | +57.90% | +98.91% | 15.82B | |
| Average | -1.07% | +5.16% | +84.30% | +97.20% | 40.98B | |
| Weighted average by Cap. | -0.73% | +7.21% | +125.06% | +54.08% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 715M 627M 590M 539M 1.01B 68.48B 1.02B 7.08B 2.75B 34.91B 2.68B 2.63B 113B | 910M 799M 751M 687M 1.28B 87.2B 1.29B 9.02B 3.5B 44.46B 3.42B 3.34B 144B |
| Net income | -95.74M -84.03M -78.99M -72.21M -135M -9.17B -136M -949M -368M -4.68B -360M -352M -15.16B | 116M 102M 95.64M 87.44M 163M 11.1B 165M 1.15B 445M 5.66B 435M 426M 18.35B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/09/26 | US$74.74 | -3.04% | 350,175 |
| 22/09/26 | US$77.08 | -0.49% | 517,016 |
| 21/09/26 | US$77.46 | -0.81% | 487,109 |
| 18/09/26 | US$78.09 | -1.19% | 710,968 |
| 17/09/26 | US$79.03 | +1.79% | 474,858 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TARS Stock
Select your edition
All financial news and data tailored to specific country editions
